Prime Highlights :
The Fortis Healthcare share price rose over 6% to ₹717.25 and was the ‘A’ group top gainer on the BSE.
The rise follows the release of excellent Q3 FY24 numbers, with net profit rising 84% year on year to ₹248 crore.
Key Facts :
The market capitalization of Fortis Healthcare stands at ₹46,441 crore and one of the top players in India’s healthcare space.
The firm reported a 15% quarter-on-quarter rise in revenue in Q3 FY24 to ₹1,928 crore.
Key Background :
Healthcare service provider Fortis Healthcare Ltd., India’s top healthcare company, reported a positive trend in shares recently when the firm’s share price increased nearly 7% to ₹717.25, becoming the top gainer in the ‘A’ group segment of the BSE. This strong market performance was backed by the company’s commendable third-quarter FY2024 financial performance. Fortis registered a net profit of ₹248 crore, 84% more than the year-ago quarter, as its top line grew 15% y-o-y to ₹1,928 crore.
Market analysts welcomed these numbers, assigning them to the firm’s prudent management and strategic efforts to make itself well established in the healthcare sector. The firm’s low debt-to-equity ratio of 0.11 is an indicator of careful financial management as well as careful capital management, which are conducive to future long-term growth opportunities.
Valuation-wise, Fortis Healthcare has a P/E of 60.39 and a P/B of 5.28, premium valuation compared with some of its peers in the industry. Nevertheless, investors appear to believe in the company’s growth trajectory fueled by its excellent operating performance and rising profitability.
In the future, Fortis Healthcare management will focus on strategic growth in the form of potential mergers and acquisitions to strengthen its competitive base. The performance of the healthy quarter and positive market response indicate the strength and long-term value creation potential of the company in the Indian healthcare industry.
Read More Article – Click Here
